About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- TipRanks: Insiders with great track records are buying these 3 stocks
- Watch: White House's Spicer gives daily briefing ahead of tax announcement
- Wells Fargo CEO's promise: We will 'fix everything that was broken'
- White House denies lawmakers’ request for info about Flynn payments
- How to save money by complaining — and actually get your way
NBR on TwitterMy Tweets
Subscribe to RSS
NBR Show Clips
Despite posting better-than-expected earnings, IBM missed revenue targets and saw its shares initially fall.
Kayla Tausche reports the latest on Trump’s meeting with health insurers, where the issue presented was whether the President will pull funding from companies that sell plans on the Affordable Care Act exchanges.
Stocks tend to dip right before taxes come due. But is the end of tax season typically a boost for the bulls? Dominic Chu takes a look.
Sue Herera reports the earnings from Dow components Goldman Sachs, UnitedHealthcare and Johnson & Johnson.
During Facebook’s Developers Conference, CEO Mark Zuckerberg addressed the Cleveland murder and Facebook’s ability to handle offensive and violent videos.
If you’re rich, there’s a bigger chance you’ll be audited this tax season by the IRS. Robert Frank reports.
China’s economy grew in the second quarter at its fastest pace since 2015, but some warning signs still remain. Eunice Yoon reports.
Markets started the week with a surprise rally, even as geopolitical tensions and soft data remain. Bob Pisani reports on why investors were in a buying mood.
In its latest quarter, Netflix saw subscriber growth in the U.S. and abroad slow down, even as the company grew profit. Julia Boorstin reports.
Meg Tirrell reports on the FDA’s rejection of Eli Lilly’s experimental rheumatoid arthritis and how the drug maker may respond to this setback.
Steve Liesman takes a look at why consumer spending isn’t rising along with consumer confidence.
Susan Li reports the latest from United Continental’s earnings report, following the company’s passenger incident last week.
Diana Olick reports on how tech companies are making it possible for people to take real-time workout classes without being in the studio.
Jackie DeAngelis reports on President Trump’s push to have infrastructure projects made with U.S. steel.
This week’s Market Monitor says we’re in a tired bull market and investors should focus on companies with strong earnings growth.